How large and important is Lonza's focus on the Indian market? What are your revenue and growth targets for India's pharma business?
Lonza India is a wholly-owned subsidiary of Switzerland-based and world's leading, integrated solutions provider for pharma and consumer healthcare. Lonza started its operations in India in 1997 as a liaison office. The office was involved mainly into sourcing advanced intermediates from India. Lonza came in as a fullfledged sales and commercial organisation with the acquisition of Cambrex Bio Products in 2007 and was renamed as Lonza India in 2008.
As India is a strategic market for the company, Lonza India has set the target of doubling its turnover by 2024 with an estimated growth of over 14 per cent. Therefore, Lonza India, recently opened its Corporate Office in Gurugram (Delhi-NCR). The new office was inaugurated by Andreas Baum, Ambassador of Switzerland to India who emphasized on India and Switzerland’s full-fledged partnership with each side benefiting from the strength of the other.
Tell us about Lonza India’s product offerings and strategic focus?
The offerings consist of products for cell discovery, molecular biology, rapid testing tools, fine chemical intermediates and pharma and intermediates for agrochemicals, consumer health and nutrition, biocides for industrial application, disinfectants for hospitals and various performance chemicals. Lonza India is now focusing on achieving the strategic vision of being a leading, integrated solutions provider for its pharma, consumer healthcare and nutrition customers all along the healthcare continuum in India.
هذه القصة مأخوذة من طبعة January 16-31, 2020 من Express Pharma.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة January 16-31, 2020 من Express Pharma.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Blissfill-Calibrated syringe pipettes for repetitive laboratory dosing as per ISO 8655-9
Blissfill syringe pipettes provide laboratories with an ergonomic, self-refilling solution for repetitive dosing, delivering precise volumes from 0.05ml to 10ml. With ISO 8655-9 compliance and an included calibration certificate, Blissfill ensures accuracy and ease of use for high-demand lab applications
Ensuring pharma compliance with testo data measurement technology
Comprehensive data measurement tools address regulatory demands and secure quality in pharma
Waters launches software for lab-centric business intelligence enabling audit readiness
waters_connect Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation
Ensuring clean room integrity with Prime Clean Reset High-Speed Doors
Designed with precision to meet the stringent requirements of controlled environments, Prime Clean Reset is the epitome of performance and reliability, ensuring that your clean room operations consistently meet the highest standards of regulatory compliance and product integrity
Optimising efficiency with Remote Laboratory Solutions
LabWare's comprehensive suite of software solutions designed specifically for laboratories offers reliable Remote Laboratory Solutions to help your business thrive in the current climate
Ensuring water quality with the 6000TOCi: The ultimate solution for continuous TOC measurement
The 6000TOCi Sensor is a comprehensive solution that brings together continuous monitoring, rapid response, reliability, and compliance
Enhancing pharmaceutical analysis in critical areas
Dheeraj Handique, Manager GC/GCMS Product Marketing, Shimadzu Analytical (India) highlights the benefits of GCMS-TQ8050 NX with HS-20 NX trap for genotoxic impurities, nitrosamines, and, extractables and leachables
Technical innovations for Annex 1
To meet the stringent EU GMP Annex 1 requirements, Optima presents innovative solutions to improve product and patient safety in pharmaceutical manufacturing. From minimising glove interventions and optimising First Air flow to advanced automation for integrity testing, this article explores how Optima's technologies support compliance in aseptic fill-and-finish processes
JRS Pharma - The Global MCC Manufacturing Network
JRS Pharma is one of the largest manufacturers of MCC across the globe. The know-how is based on more than 25 years of experience in development of own processes
Mack Pharmatech is the first to launch PLC-based environmental chambers in India
Manoj Choudhari, Managing Director, Mack Pharmatech shares insights on his company's pioneering expand globally and enhance regulatory compliance